• ERESEARCHTECHNOLOGY INC Profile

    eResearchTechnology (eRT) e-cares about your e-clinical e-trial. The firm offers support services and software to help streamline the clinical trials process that drugs and medical devices must pass to earn regulatory approval. eRT's products automate all aspects of the process, from setup and data gathering to analysis and FDA application preparation. Customers include drugmakers, medical device firms, and contract research organizations (CROs). Flagship product EXPeRT ensures cardiac safety by collecting, processing, and interpreting electrocardiogram (ECG) data. eRT also provides site support including ECG equipment rentals and sales. The firm markets its products through a global sales force.
    Michael J. McKelvey, Ph.D.
    CEO
    30 S. 17th St.

    Philadelphia, PA 19103-4001

    http://www.ert.com

    Phone: 215-972-0420

    Fax: 215-972-0414
    Sector: Healthcare Industry: Health Services
  • 2007 Sales 2007 Sales Growth 2007 Net Income Employees
    $86,800,000 0.6% $15,400,000
  • Key Executives: ERES

    Name Title Officer Since
    Michael J. McKelvey, Ph.D. CEO 7/25/06
    Steven M. Eisenstein CFO -
    Jeffrey S. Litwin, M.D. Chief Medical Officer -
    Joel Morganroth, M.D. Chief Scientific Officer 1/1/97
    Thomas P. Devine Executive VP -
    Dr. Gerald A. Faich, M.D., MPH Director 1/1/04
    Amy Furlong Executive VP, Divisional -
    Richard A. Baron -
  • Top Competitors: ERES

  • Insider Trends: ERES

    Sentiment for ERES is NEGATIVE

    • 0M
    • 2M
    • 4M
    • 6M
    • Market Value of Insider Sales
    • Market Value of Insider Purchases
    Total dollar value of all insider purchases and sales over 12 months
  • Insider Transactions: ERES

    Date Name Shares Transaction Type Market Value
    06/25/08 PHILLIPS STEPHEN S 1,140 Stock Gift $0.00
    06/12/08 LITWIN JEFFREY S 10,000 Sale $160,063.16
    05/19/08 JEFFREY LITWIN TRUST 20,000 Planned Sale $319,000.00
  • Ownership Breakdown : ERES

    Large Block Holder Type Number  
    Institutions 152.00
     
    Mutual Fund 195.00
    Other Major 9.00
  • Short Interest Volume: ERES

    Data as of 6/10/08
    Current Short Interest Shares 1.10 B
    Current Short Interest Ratio 8.50
    Float 48.40 M
    Short Interest as % of Float 8.50
    Average Daily Volume 611,000.00
    Outstanding Shares 50.67 M